High levels of AAbs that neutralize GM-CSF signaling cause autoimmune pulmonary alveolar proteinosis (aPAP), an ultrarare autoimmune disease characterized by accumulation of excess surfactant in the alveoli, leading to pulmonary insufficiency. This evidence concerns the gene CSF2 and autoimmune pulmonary alveolar proteinosis.